MOLLY O'NEILL: Open Payments
NPI 1740993385 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 27 payments from 11 companies in 2025. Trend: 2023 $710 · 2024 $571 · 2025 $665
Food & beverage: $573Education: $92
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $107 |
| UCB, Inc. | 4 | $95 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| ABBVIE INC. | 3 | $74 |
| Lilly USA, LLC | 3 | $71 |
| GENZYME CORPORATION | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Janssen Biotech, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $17 |
Products named: DUPIXENT, Bimzelx, TALTZ, RINVOQ, HADLIMA, COSENTYX, TREMFYA, Rhapsido.
Industry payments across MA — which companies pay providers there.
